Liqian Xu
Overview
Explore the profile of Liqian Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang J, Xu L, Zhang K, Yue J, Dong K, Luo Q, et al.
BMC Microbiol
. 2024 Oct;
24(1):430.
PMID: 39455935
Objectives: The aim of this study was to identify the synergistic effect and mechanisms of fosfomycin (FM) combined with colistin (COL) against KPC-producing Klebsiella pneumoniae (KPC-Kp). Methods: The bactericidal effects,...
2.
Ying L, Xu L, Yang J, Zhang Q
Sci Rep
. 2024 May;
14(1):12025.
PMID: 38797769
Sarcopenia has been associated with higher toxicity induced by anti-cancer treatments and shorter survival in patients with squamous cell lung carcinoma (SqCLC). Over the past few decades, immune checkpoint inhibitors...
3.
Wu K, Xu L, Li X, Zhang Y, Yue Z, Gao Y, et al.
Comput Biol Chem
. 2023 Nov;
108:107977.
PMID: 37995493
Named Entity Recognition (NER) is a fundamental but crucial task in natural language processing (NLP) and big data analysis, with wide application range. NER for rice genes and phenotypes is...
4.
Huang Y, Liu Q, Liu M, Xu L, Li Y, Chen Q, et al.
J Biomol Struct Dyn
. 2023 Nov;
42(23):12935-12953.
PMID: 37921741
Chronic heart failure (CHF) is the primary cause of death among patients with cardiovascular diseases, representing the advanced stage in the development of several cardiovascular conditions. Zhenwu decoction (ZWD) has...
5.
Huang Y, Dong X, Xu L, Cao X, Sun S
Complement Ther Clin Pract
. 2023 Jan;
51:101721.
PMID: 36669325
Objective: This study aimed to compare the effect of concurrent training and the addition of health education and nutrition management on body composition and health-related outcomes. Methods: Twenty-four healthy overweight...
6.
Liao M, Chen R, Yang Y, He H, Xu L, Jiang Y, et al.
Acta Pharm Sin B
. 2022 Mar;
12(2):678-691.
PMID: 35256939
Aging-elevated DNMT3A R882H-driven clonal hematopoiesis (CH) is a risk factor for myeloid malignancies remission and overall survival. Although some studies were conducted to investigate this phenomenon, the exact mechanism is...
7.
Wang J, Xu L, Huang S, Hui Q, Shi X, Zhang Q
BMC Geriatr
. 2021 Dec;
21(1):730.
PMID: 34949161
Background: Sarcopenia is one of the most frequent syndromes in older adults and one of its main characteristics is low muscle mass. Gastrointestinal tumor is a malignant disease with high...
8.
Liao M, Dong Q, Chen R, Xu L, Jiang Y, Guo Z, et al.
Cell Death Discov
. 2021 Oct;
7(1):297.
PMID: 34663800
DNA (cytosine-5)-methyltransferase 3A (DNMT3A) mutations occur in ~20% of de novo acute myeloid leukemia (AML) patients, and >50% of these mutations in AML samples are heterozygous missense alterations within the...
9.
Cui C, Zhang D, Sun K, Li H, Xu L, Lin G, et al.
Int J Mol Med
. 2021 May;
48(1).
PMID: 34036377
Propofol is a commonly used intravenous anesthetic. The aim of the study was to examine the mechanism of propofol in traumatic brain injury (TBI) by regulating interleukin (IL)‑17 activity and...
10.
Wang P, Xu L, Yang Y
Front Oncol
. 2021 May;
11:629597.
PMID: 34026609
Background: Angiosarcoma is a rare, highly malignant tumor prone to recurrence and metastasis. Angiosarcoma is insidious in the initial stage, and its clinical manifestation lacks specificity. The diagnosis is based...